Oct 1, 2020 | Cancer Center News
Researchers affiliated with the Cancer Center at Illinois discovered a novel small molecule compound that is now the subject of a new global licensing agreement between the pharmaceutical company Bayer AG and the cancer drug development company Systems Oncology LLC....
Aug 31, 2020 | Cancer Center News
When assessing whether or not a tumor is benign or cancerous, a needle biopsy is the usual method of diagnosis. The tissue can then be analyzed to determine what mutations are present that are specific to the patient. Because this method is invasive, it’s generally...
Jul 16, 2020 | Cancer Center News
Tim Fan, CCIL Research Program Leader and professor of Veterinary Clinical Medicine, discusses how companion animals can assist researchers in improving cancer treatments. Comparative oncology with pets can expedite human clinical trials and the animal data can better...
Jun 18, 2020 | Cancer Center News
The Cancer Center at Illinois at the University of Illinois at Urbana-Champaign is supporting three new cancer research projects through its planning grant initiative. Recipients will each receive up to $25,000 to spark innovative research projects that have promise...
Feb 6, 2020 | Cancer Center News
Two grants will fund interdisciplinary research at the Beckman Institute for Advanced Science and Technology, including a look at how neurons and muscle cells communicate with each other and also to develop a drug delivery system for treatment of Alzheimer’s disease....
Nov 20, 2019 | Cancer Center News
The team includes, from left, graduate student Emily Geddes, pathobiology professor Gee Lau, chemistry professor Paul Hergenrother, postdoctoral researcher Hyang Yeon Lee, and postdoctoral researcher Erica Parker. Paul Hergenrother, professor of chemistry,...
Nov 2, 2019 | Cancer Center News, Student Spotlight
Sisi He, PhD Candidate, Molecular and Integrative Physiology TiMe 2016 CohortC*STAR 2017 Cohort What first led to your interest in cancer research? I studied Chemistry and Biochemistry at UW-Madison for my Bachelor’s degree. Afterward, I came here to pursue doctoral...
Aug 2, 2019 | Cancer Center News, Student Spotlight
Bingtao Tang, PhD Candidate, Molecular and Integrative Physiology C*STAR Program, 2018 Cohort What led to your interest in cancer research? I received my bachelor’s degree in bioengineering from Xi’an Jiaotong University in China. After that, I came to the...
May 21, 2018 | Cancer Center News
Illinois professor Andrew Smith, right, and graduate student Mohammad Zahid. With targeted drug and gene therapies, finding the target cells is only half the battle. Once these agents reach a cell’s surface, they still have to get inside and do their job. University...
Apr 9, 2018 | Cancer Center News
Image of Emerging Pathway of Doxorubin Cardiotoxicity. ABSTRACTDoxorubicin (DOX) is among the oldest and most-used chemotherapeutics. However, its use is limited by a cumulative dose that leads to cardiotoxicity. DOX is an anthracycline quinone that is known to...
Apr 3, 2018 | Cancer Center News
Image of William Arnold, a graduate student in biochemistry, and Aditi Das, an assistant professor of biochemistry and bioengineering graduate program. There are many anti-cancer therapeutics that are effective at killing cancer, but some can have serious side...
Mar 3, 2018 | Cancer Center News
Image of T-Cell. T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can’t match, but the field is still looking for a clear success. Last September, GlaxoSmithKline took over one of Adaptimmune Therapeutics’...
